JCR
Live / Applied — Third extension granted (statement of use) (as of 14 Oct 2025)
What this means for you
Not registered yet, but its 26 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97909440
- Mark type
- Design + words
- Filed
- 26 Apr 2023
- Published for opposition
- 23 Apr 2024
- Attorney of record
- Peter S. Weissman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of diseases and disorders affecting the otorhinolaryngological system, sensory system, skeletal system, articular system, respiratory system, cardiovascular system, digestive system, central nervous system, peripheral nervous system, endocrine system, and muscular system; pharmaceutical preparations for the treatment and prevention of growth disorders, otorhinolaryngological disorders, eye disorders, skeletal disorders, joint disorders, cardiovascular disorders, digestive disorders, neurological disorders, endocrine disorders, muscular disorders, metabolic disorders, lysosomal diseases, and genetic disorders
Owner
- JCR PHARMACEUTICALS CO., LTD., Ashiya-shi, Hyogo, JP
- JCR PHARMACEUTICALS CO., LTD., Ashiya-shi, Hyogo, JP
Prosecution history
- 15 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2025 — SOU EXTENSION 3 GRANTED
- 14 Oct 2025 — SOU EXTENSION 3 FILED
- 14 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 2 GRANTED
- 17 Jun 2025 — SOU EXTENSION 2 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Oct 2024 — SOU EXTENSION 1 GRANTED
- 30 Oct 2024 — SOU EXTENSION 1 FILED
- 30 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION